My Profile Shopping Cart Register Login
Logo and Name
 
CME/CE Programs About Us Why Register? Advisory Panel Links Contact Home
 
 
Current Topics
Videoclip: Molecular Biology of GBM
Watch this brief video of a radiation oncologist, neurosurgeon, and neuro-oncologist, discussing tre
MORE

Evaluating New Brain Masses
Patients who present with newly diagnosed brain masses usually have some symptomatic combination of
MORE

Treating the Elderly with Malignant Glioma
Is 70 the "New 60”?
When considering how aggressively to treat an elderly patient with
MORE

Recurrent GBM
Unfortunately, almost all glioblastomas (GBMs) recur despite aggressive treatment with surgery, radi
MORE

MGMT and Its Role in GBM
Combining temozolomide (TMZ), an oral cytotoxic agent with concomitant radiation therapy (XRT) has b
MORE

Treating Newly Diagnosed GBM
Glioblastoma multiforme (GBM) is a primary brain tumor classified by the World Health Organization a
MORE

Future Hope for Long-Term GBM Survival?
The conversation around prognosis for a patient with newly diagnosed glioblastoma is becoming increa
MORE

Polymer-Based Local Therapy
High-grade gliomas are aggressive tumors that usually recur locally despite aggressive multimodality
MORE

Newly Diagnosed Oligos
Treatment for newly diagnosed anaplastic oligodendrogliomas is controversial. Oligodendrogliomas ar
MORE

Imaging Alternatives
Conventional computed tomography (CT) and magnetic resonance imaging (MRI) scans provide structural
MORE

The PK of TMZ
Temozolomide (TMZ), an oral alkylating agent, is rapidly absorbed and spontaneously converts to the
MORE

The Role of MGMT
Cytotoxic stress by chemotherapy or radiation induces upregulation of methyl-guanine methyl transfer
MORE

New Standard of Care for GBM
Phase II data initially suggested that temozolomide (TMZ) may be efficacious for malignant gliomas w
MORE

Molecular Markers
There’s a lot of excitement about molecular markers such as methyl-guanine methyltransferase (MGMT),
MORE